Klotho

Klotho

α-Klotho (soluble fragment)

Anti-aging protein — overexpression extends mouse lifespan ~30%

LongevityAnti-Aging ★ 58
Half-life
Short circulating (~30 min) but effects sustained via gene expression changes.
Cycle
Long cycles tolerated. Conservative protocol: 12-24 weeks on, 8 weeks off.
Storage
Lyophilized: -20°C freezer. Reconstituted: 2-8°C, 14 days.
Research
Highly experimental as therapy. Strong genetic / preclinical data; no FDA-approved human peptide therapy yet. Compounding pharmacies offer research-grade.

About

Soluble α-klotho is a circulating fragment of the Klotho protein, named after the Greek fate who spins the thread of life. Mice engineered to overexpress klotho live 30% longer; klotho-deficient mice age prematurely.

Mechanism

Co-receptor for FGF23 (phosphate homeostasis); inhibits insulin/IGF-1 signaling (longevity pathway); enhances antioxidant FOXO transcription; modulates Wnt and TGF-β signaling.

Dosage

100 mcg
1x per week
0102030405060708090100

Draw to 10 units on a U-100 insulin syringe

1 mg · 1 mL BAC

Route
Subcutaneous (SubQ)
Duration
12 weeks (one cycle)

When to take: Any time; weekly cadence makes timing less important.

Reconstitution

Vial size (mg): 1 mg · BAC water (mL): 1 mL · Concentration: 1 mg/mL

Expensive — measure precisely. Sensitive to heat; keep cold throughout.

Benefits

  • Possible lifespan extension (animal data)
  • Cognitive protection (Alzheimer models)
  • Cardiovascular protection
  • Kidney protection
  • Bone density maintenance
  • Insulin/IGF-1 axis modulation

Side effects

  • Limited human data — side effects largely unknown
  • Theoretical: altered phosphate metabolism (FGF23 co-receptor effects)
  • Animal studies show good tolerability

Gender notes

Same dose. Popular in advanced longevity stacks.

Cautions

  • Pregnancy and breastfeeding
  • Chronic kidney disease (phosphate metabolism interaction)
  • Hyperphosphatemia
  • Active cancer (insufficient data on tumor signaling impact)

Research

Stacks well with